RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,191,264 | +26095.4% | 182,825 | +25152.1% | 0.00% | – |
| Q2 2020 | $16,000 | +45.5% | 724 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | -35.3% | 724 | -3.2% | 0.00% | – |
| Q4 2019 | $17,000 | +6.2% | 748 | 0.0% | 0.00% | – |
| Q3 2019 | $16,000 | -97.6% | 748 | -97.6% | 0.00% | -100.0% |
| Q2 2019 | $677,000 | -19.8% | 30,795 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $844,000 | +1.9% | 30,795 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $828,000 | -7.9% | 30,792 | -0.0% | 0.00% | 0.0% |
| Q3 2018 | $899,000 | -6.7% | 30,807 | -0.2% | 0.00% | 0.0% |
| Q2 2018 | $964,000 | +26.7% | 30,854 | -19.4% | 0.00% | 0.0% |
| Q1 2018 | $761,000 | +1363.5% | 38,264 | +2040.0% | 0.00% | – |
| Q4 2017 | $52,000 | – | 1,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |